|
1
|
Good DM, Thongboonkerd V, Novak J,
Bascands JL, Schanstra JP, Coon JJ, Dominiczak A and Mischak H:
Body fluid proteomics for biomarker discovery: Lessons from the
past hold the key to success in the future. J Proteome Res.
6:4549–4555. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Marshall T and Williams K: Two-dimensional
electrophoresis of human urinary proteins following concentration
by dye precipitation. Electrophoresis. 17:1265–1272. 1996.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Pieper R, Gatlin CL, McGrath AM, Makusky
AJ, Mondal M, Seonarain M, Field E, Schatz CR, Estock MA, Ahmed N,
et al: Characterization of the human urinary proteome: A method for
high-resolution display of urinary proteins on two-dimensional
electrophoresis gels with a yield of nearly 1400 distinct protein
spots. Proteomics. 4:1159–1174. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Büeler MR, Wiederkehr F and Vonderschmitt
DJ: Electrophoretic, chromatographic and immunological studies of
human urinary proteins. Electrophoresis. 16:124–134. 1995.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Spahr CS, Davis MT, McGinley MD, Robinson
JH, Bures EJ, Beierle J, Mort J, Courchesne PL, Chen K, Wahl RC, et
al: Towards defining the urinary proteome using liquid
chromatography-tandem mass spectrometry. I Profiling an
unfractionated tryptic digest. Proteomics. 1:93–107. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Cadieux PA, Beiko DT, Watterson JD, Burton
JP, Howard JC, Knudsen BE, Gan BS, McCormick JK, Chambers AF,
Denstedt JD, et al: Surface-enhanced laser
desorption/ionization-time of flight-mass spectrometry
(SELDI-TOF-MS): A new proteomic urinary test for patients with
urolithiasis. J Clin Lab Anal. 18:170–175. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Roelofsen H, Alvarez-Llamas G, Schepers M,
Landman K and Vonk RJ: Proteomics profiling of urine with surface
enhanced laser desorption/ionization time of flight mass
spectrometry. Proteome Sci. 5:22007. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Vanhoutte KJ, Laarakkers C, Marchiori E,
Pickkers P, Wetzels JF, Willems JL, van den Heuvel LP, Russel FG
and Masereeuw R: Biomarker discovery with SELDI-TOF MS in human
urine associated with early renal injury: Evaluation with
computational analytical tools. Nephrol Dial Transplant.
22:2932–2943. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Husi H, Stephens N, Cronshaw A, MacDonald
A, Gallagher I, Greig C, Fearon KC and Ross JA: Proteomic analysis
of urinary upper gastrointestinal cancer markers. Proteomics Clin
Appl. 5:289–299. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Petri AL, Simonsen AH, Yip TT, Hogdall E,
Fung ET, Lundvall L and Hogdall C: Three new potential ovarian
cancer biomarkers detected in human urine with equalizer bead
technology. Acta Obstet Gynecol Scand. 88:18–26. 2009. View Article : Google Scholar
|
|
11
|
Tsui KH, Tang P, Lin CY, Chang PL, Chang
CH and Yung BY: Bikunin loss in urine as useful marker for bladder
carcinoma. J Urol. 183:339–344. 2010. View Article : Google Scholar
|
|
12
|
Chen YT, Chen CL, Chen HW, Chung T, Wu CC,
Chen CD, Hsu CW, Chen MC, Tsui KH, Chang PL, et al: Discovery of
novel bladder cancer biomarkers by comparative urine proteomics
using iTRAQ technology. J Proteome Res. 9:5803–5815. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Tan LB, Chen KT, Yuan YC, Liao PC and Guo
HR: Identification of urine PLK2 as a marker of bladder tumors by
proteomic analysis. World J Urol. 28:117–122. 2010. View Article : Google Scholar
|
|
14
|
Xue A, Scarlett CJ, Chung L, Butturini G,
Scarpa A, Gandy R, Wilson SR, Baxter RC and Smith RC: Discovery of
serum biomarkers for pancreatic adenocarcinoma using proteomic
analysis. Br J Cancer. 103:391–400. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Schröder C, Jacob A, Tonack S, Radon TP,
Sill M, Zucknick M, Rüffer S, Costello E, Neoptolemos JP,
Crnogorac-Jurcevic T, et al: Dual-color proteomic profiling of
complex samples with a microarray of 810 cancer-related antibodies.
Mol Cell Proteomics. 9:1271–1280. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Good DM, Zürbig P, Argilés A, Bauer HW,
Behrens G, Coon JJ, Dakna M, Decramer S, Delles C, Dominiczak AF,
et al: Naturally occurring human urinary peptides for use in
diagnosis of chronic kidney disease. Mol Cell Proteomics.
9:2424–2437. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Zhang Y, Zhang Y, Adachi J, Olsen JV, Shi
R, de Souza G, Pasini E, Foster LJ, Macek B, Zougman A, et al:
MAPU: Max-Planck Unified database of organellar, cellular, tissue
and body fluid proteomes. Nucleic Acids Res. 35:D771–D779. 2007.
View Article : Google Scholar :
|
|
18
|
Li SJ, Peng M, Li H, Liu BS, Wang C, Wu
JR, Li YX and Zeng R: Sys-BodyFluid: A systematical database for
human body fluid proteome research. Nucleic Acids Res.
37:D907–D912. 2009. View Article : Google Scholar :
|
|
19
|
Agron IA, Avtonomov DM, Kononikhin AS,
Popov IA, Moshkovskii SA and Nikolaev EN: Accurate mass tag
retention time database for urine proteome analysis by
chromatography-mass spectrometry. Biochemistry (Mosc). 75:636–641.
2010. View Article : Google Scholar
|
|
20
|
Carson JM, Okamura K, Wakashin H, McFann
K, Dobrinskikh E, Kopp JB and Blaine J: Podocytes degrade
endocytosed albumin primarily in lysosomes. PLoS One. 9:e997712014.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Collins MO, Yu L and Choudhary JS:
Analysis protein complexes by 1D-SDS-PAGE and tandem mass
spectrometry. Protocol Exchange. 2008. View Article : Google Scholar
|
|
22
|
Kentsis A, Monigatti F, Dorff K, Campagne
F, Bachur R and Steen H: Urine proteomics for profiling of human
disease using high accuracy mass spectrometry. Proteomics Clin
Appl. 3:1052–1061. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Adachi J, Kumar C, Zhang Y, Olsen JV and
Mann M: The human urinary proteome contains more than 1500
proteins, including a large proportion of membrane proteins. Genome
Biol. 7:R802006. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Gonzales PA, Pisitkun T, Hoffert JD,
Tchapyjnikov D, Star RA, Kleta R, Wang NS and Knepper MA:
Large-scale proteomics and phosphoproteomics of urinary exosomes. J
Am Soc Nephrol. 20:363–379. 2009. View Article : Google Scholar :
|
|
25
|
Chang KW, Yang PY, Lai HY, Yeh TS, Chen TC
and Yeh CT: Identification of a novel actin isoform in
hepatocellular carcinoma. Hepatol Res. 36:33–39. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Hunecke D, Spanel R, Länger F, Nam SW and
Borlak J: MYC-regulated genes involved in liver cell dysplasia
identified in a transgenic model of liver cancer. J Pathol.
228:520–533. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Liu Y, Zhu X, Zhu J, Liao S, Tang Q, Liu
K, Guan X, Zhang J and Feng Z: Identification of differential
expression of genes in hepatocellular carcinoma by suppression
subtractive hybridization combined cDNA microarray. Oncol Rep.
18:943–951. 2007.PubMed/NCBI
|
|
28
|
Park JH, Nishidate T, Kijima K, Ohashi T,
Takegawa K, Fujikane T, Hirata K, Nakamura Y and Katagiri T:
Critical roles of mucin 1 glycosylation by transactivated
polypeptide N-acetylgalactosaminyltransferase 6 in mammary
carcinogenesis. Cancer Res. 70:2759–2769. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Long J, Zhang B, Signorello LB, Cai Q,
Deming-Halverson S, Shrubsole MJ, Sanderson M, Dennis J,
Michailidou K, Easton DF, et al: Evaluating genome-wide association
study-identified breast cancer risk variants in African-American
women. PLoS One. 8:e583502013. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Fukukawa C, Ueda K, Nishidate T, Katagiri
T and Nakamura Y: Critical roles of LGN/GPSM2 phosphorylation by
PBK/TOPK in cell division of breast cancer cells. Genes Chromosomes
Cancer. 49:861–872. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Yang ZQ, Liu G, Bollig-Fischer A, Giroux
CN and Ethier SP: Transforming properties of 8p11–12 amplified
genes in human breast cancer. Cancer Res. 70:8487–8497. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Heyn H, Carmona FJ, Gomez A, Ferreira HJ,
Bell JT, Sayols S, Ward K, Stefansson OA, Moran S, Sandoval J, et
al: DNA methylation profiling in breast cancer discordant identical
twins identifies DOK7 as novel epigenetic biomarker.
Carcinogenesis. 34:102–108. 2013. View Article : Google Scholar :
|
|
33
|
Kauppinen JM, Kosma VM, Soini Y, Sironen
R, Nissinen M, Nykopp TK, Kärjä V, Eskelinen M, Kataja V and
Mannermaa A: ST14 gene variant and decreased matriptase protein
expression predict poor breast cancer survival. Cancer Epidemiol
Biomarkers Prev. 19:2133–2142. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Hattori N, Okochi-Takada E, Kikuyama M,
Wakabayashi M, Yamashita S and Ushijima T: Methylation silencing of
angio-poietin-like 4 in rat and human mammary carcinomas. Cancer
Sci. 102:1337–1343. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Ni S, Xu L, Huang J, Feng J, Zhu H, Wang G
and Wang X: Increased ZO-1 expression predicts valuable prognosis
in non-small cell lung cancer. Int J Clin Exp Pathol. 6:2887–2895.
2013.PubMed/NCBI
|
|
36
|
Paulo P, Ribeiro FR, Santos J, Mesquita D,
Almeida M, Barros-Silva JD, Itkonen H, Henrique R, Jerónimo C,
Sveen A, et al: Molecular subtyping of primary prostate cancer
reveals specific and shared target genes of different ETS
rearrangements. Neoplasia. 14:600–611. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Blum R, Gupta R, Burger PE, Ontiveros CS,
Salm SN, Xiong X, Kamb A, Wesche H, Marshall L, Cutler G, et al:
Molecular signatures of prostate stem cells reveal novel signaling
pathways and provide insights into prostate cancer. PLoS One.
4:e57222009. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Battaglia S, Maguire O, Thorne JL, Hornung
LB, Doig CL, Liu S, Sucheston LE, Bianchi A, Khanim FL, Gommersall
LM, et al: Elevated NCOR1 disrupts PPARalpha/gamma signaling in
prostate cancer and forms a targetable epigenetic lesion.
Carcinogenesis. 31:1650–1660. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Quinn MC, Filali-Mouhim A, Provencher DM,
Mes-Masson AM and Tonin PN: Reprogramming of the transcriptome in a
novel chromosome 3 transfer tumor suppressor ovarian cancer cell
line model affected molecular networks that are characteristic of
ovarian cancer. Mol Carcinog. 48:648–661. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Quyun C, Ye Z, Lin SC and Lin B: Recent
patents and advances in genomic biomarker discovery for colorectal
cancers. Recent Pat DNA Gene Seq. 4:86–93. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Cancer Genome Atlas Network. Comprehensive
molecular characterization of human colon and rectal cancer.
Nature. 487:330–337. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Watanabe Y, Castoro RJ, Kim HS, North B,
Oikawa R, Hiraishi T, Ahmed SS, Chung W, Cho MY, Toyota M, et al:
Frequent alteration of MLL3 frameshift mutations in microsatellite
deficient colorectal cancer. PLoS One. 6:e233202011. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Shain AH, Salari K, Giacomini CP and
Pollack JR: Integrative genomic and functional profiling of the
pancreatic cancer genome. BMC Genomics. 14:6242013. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Liu H, Ma Q and Li J: High glucose
promotes cell proliferation and enhances GDNF and RET expression in
pancreatic cancer cells. Mol Cell Biochem. 347:95–101. 2011.
View Article : Google Scholar
|
|
45
|
Fernstad R, Pousette A, Carlström K and
Sköldefors H: A novel assay for pancreatic cellular damage: IV.
Serum concentrations of pancreas-specific protein (PASP) in acute
pancreatitis and other abdominal diseases. Pancreas. 5:42–49. 1990.
View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Hansel DE, Rahman A, House M, Ashfaq R,
Berg K, Yeo CJ and Maitra A: Met proto-oncogene and insulin-like
growth factor binding protein 3 overexpression correlates with
metastatic ability in well-differentiated pancreatic endocrine
neoplasms. Clin Cancer Res. 10:6152–6158. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Iio A, Takagi T, Miki K, Naoe T, Nakayama
A and Akao Y: DDX6 post-transcriptionally down-regulates
miR-143/145 expression through host gene NCR143/145 in cancer
cells. Biochim Biophys Acta. 1829:1102–1110. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Bai RY, Koester C, Ouyang T, Hahn SA,
Hammerschmidt M, Peschel C and Duyster J: SMIF, a Smad4-interacting
protein that functions as a co-activator in TGFbeta signaling. Nat
Cell Biol. 4:181–190. 2002. View
Article : Google Scholar : PubMed/NCBI
|
|
49
|
Lu YC, Yao X, Crystal JS, Li YF, El-Gamil
M, Gross C, Davis L, Dudley ME, Yang JC, Samuels Y, et al:
Efficient identification of mutated cancer antigens recognized by T
cells associated with durable tumor regressions. Clin Cancer Res.
20:3401–3410. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Fernández-Sáiz V, Targosz BS, Lemeer S,
Eichner R, Langer C, Bullinger L, Reiter C, Slotta-Huspenina J,
Schroeder S, Knorn AM, et al: SCFFbxo9 and CK2 direct the cellular
response to growth factor withdrawal via Tel2/Tti1 degradation and
promote survival in multiple myeloma. Nat Cell Biol. 15:72–81.
2013. View Article : Google Scholar
|
|
51
|
Lee LR, Teng PN, Nguyen H, Hood BL,
Kavandi L, Wang G, Turbov JM, Thaete LG, Hamilton CA, Maxwell GL,
et al: Progesterone enhances calcitriol antitumor activity by
upregulating vitamin D receptor expression and promoting apoptosis
in endometrial cancer cells. Cancer Prev Res (Phila). 6:731–743.
2013. View Article : Google Scholar
|
|
52
|
Giefing M, Zemke N, Brauze D,
Kostrzewska-Poczekaj M, Luczak M, Szaumkessel M, Pelinska K,
Kiwerska K, Tönnies H, Grenman R, et al: High resolution ArrayCGH
and expression profiling identifies PTPRD and PCDH17/PCH68 as tumor
suppressor gene candidates in laryngeal squamous cell carcinoma.
Genes Chromosomes Cancer. 50:154–166. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Al-Shali K, Wang J, Rosen F and Hegele RA:
Ileal adenocarcinoma in a mild phenotype of abetalipoproteinemia.
Clin Genet. 63:135–138. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
54
|
Silvério R, Laviano A, Rossi Fanelli F and
Seelaender M: L-Carnitine induces recovery of liver lipid
metabolism in cancer cachexia. Amino Acids. 42:1783–1792. 2012.
View Article : Google Scholar
|
|
55
|
Hjortland GO, Meza-Zepeda LA, Beiske K,
Ree AH, Tveito S, Hoifodt H, Bohler PJ, Hole KH, Myklebost O,
Fodstad O, et al: Genome wide single cell analysis of chemotherapy
resistant metastatic cells in a case of gastroesophageal
adenocarcinoma. BMC Cancer. 11:4552011. View Article : Google Scholar : PubMed/NCBI
|
|
56
|
Adachi R, Horiuchi S, Sakurazawa Y,
Hasegawa T, Sato K and Sakamaki T: ErbB2 down-regulates
microRNA-205 in breast cancer. Biochem Biophys Res Commun.
411:804–808. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
57
|
Janku F, Garrido-Laguna I, Petruzelka LB,
Stewart DJ and Kurzrock R: Novel therapeutic targets in non-small
cell lung cancer. J Thorac Oncol. 6:1601–1612. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
58
|
Goldin RD and Roa JC: Gallbladder cancer:
A morphological and molecular update. Histopathology. 55:218–229.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
59
|
Komoto M, Nakata B, Amano R, Yamada N,
Yashiro M, Ohira M, Wakasa K and Hirakawa K: HER2 overexpression
correlates with survival after curative resection of pancreatic
cancer. Cancer Sci. 100:1243–1247. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
60
|
Elsahwi KS and Santin AD: erbB2
overexpression in uterine serous cancer: A molecular target for
trastuzumab therapy. Obstet Gynecol Int. 2011:1282952011.
View Article : Google Scholar : PubMed/NCBI
|
|
61
|
Mazzio EA, Boukli N, Rivera N and Soliman
KF: Pericellular pH homeostasis is a primary function of the
Warburg effect: Inversion of metabolic systems to control lactate
steady state in tumor cells. Cancer Sci. 103:422–432. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
62
|
Hu Y, Wang J, Yang B, Zheng N, Qin M, Ji
Y, Lin G, Tian L, Wu X, Wu L, et al: Guanylate binding protein 4
negatively regulates virus-induced type I IFN and antiviral
response by targeting IFN regulatory factor 7. J Immunol.
187:6456–6462. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
63
|
Maes T, Barceló A and Buesa C: Neuron
navigator: A human gene family with homology to unc-53, a cell
guidance gene from Caenorhabditis elegans. Genomics. 80:21–30.
2002. View Article : Google Scholar : PubMed/NCBI
|
